Quantcast
Last updated on April 18, 2014 at 21:21 EDT

Patheon to Host Complimentary Seminar on “Getting Your Drug through Phase I Early Development Effectively” at Milton Park, UK Facility

February 9, 2013

The seminar will be held on Tuesday, February 19th at 11:30 — 6 p.m. Central European Time at Patheon´s Milton Park facility in Oxfordshire, UK.

(PRWEB) February 08, 2013

Patheon Inc., a leading provider of contract development and commercial manufacturing services to the global pharmaceutical industry, today announced that it will be hosting a complimentary seminar on “Getting Your Drug Through Phase I Early Development Effectively”. The seminar will be held on Tuesday, February 19th at 11:30 — 6 p.m. Central European Time at Patheon´s Milton Park facility in Oxfordshire, UK.

Patheon recently announced its plans to launch the company´s SoluPath program at the Milton Park facility as part of the company´s global strategy to expand early pharmaceutical development services for its customers.

In the upcoming seminar, Patheon have invited three scientific leaders to share their experiences and answer questions on strategies for effectively progressing small molecules through early drug development. Presentations will be provided by Patheon employees, Jon Sutch, Ph.D., and Rick Bastin, as well as from Paul Madeley, Ph.D., with Synth-Isis Ltd. Through case studies and interactive presentations, presenters will discuss early stages of active pharmaceutical ingredient (API) development, formulation strategies and challenges of low solubility and bioavailability. There will also be an opportunity to pose technical questions to the company´s experts through the Ask the Experts round table. Visit Patheon´s website to learn more or register for the upcoming seminar.

About Patheon Inc.

Patheon Inc. (TSX: PTI) is a leading provider of contract development and commercial manufacturing services to the global pharmaceutical industry for a full array of solid and sterile dosage forms. Through the company´s recent acquisition of Banner Pharmacaps — a market leader in soft gelatin capsule technology — Patheon now also includes a proprietary products and technology business.

Patheon provides the highest quality products and services to approximately 300 of the world’s leading pharmaceutical and biotechnology companies. The company’s integrated network consists of 18 locations, including 14 commercial contract manufacturing facilities and 12 development centers across North America and Europe. Patheon enables customer products to be launched with confidence anywhere in the world. For more information visit http://www.patheon.com.

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2013/2/prweb10403198.htm


Source: prweb